atovaquone - CISMeF

Preferred Label : atovaquone;

MeSH definition : A hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols.;

MeSH synonym : 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone; 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone;

CISMeF synonym : 566C80, hydroxynaphthoquinone; GlaxoSmithKline brand of atovaquone; atovaquone GlaxoSmithKline brand; glaxo wellcome brand of atovaquone; wellvone;

DeCS synonym : Wellvone;

MeSH hyponym : mepron; 566C; 566C80; compound 566; hydroxynaphthoquinone 566C80; 566C80 hydroxynaphthoquinone; hydroxynaphthoquinone, 566C80;

MeSH CAS label : 3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione;

MeSH Related Number : 94015-53-9 (Atovaquone);

Registry Number MeSH : 94015-53-9;

Wikipedia link : https://en.wikipedia.org/wiki/Atovaquone;

Is substance : O;

UNII : Y883P1Z2LT;

InChIKey : KUCQYCKVKVOKAY-CTYIDZIISA-N;

Details

Origin ID

D053626;

UMLS CUI

C0165603;

ATC code(s)
- atovaquone [ATC Code]
ATC code(s)
- atovaquone [ATC Code]
- proguanil and atovaquone [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- 1,4-naphthalenedione, 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-, trans- [Substance BNPC]
- Atovaquone [LOINC component]
- Atovaquone [ICD-11 Extension code]
- Atovaquone [SMS substance]
- Atovaquone [NCIt concept]
- Atovaquone (substance) [SNOMED CT concept]
Pharmacological action(s)
- antimalarials [MeSH Descriptor]
- enzyme inhibitors [MeSH Descriptor]
Record concept(s)
- 566C [MeSH concept]
- 566C80 [MeSH concept]
- Wellvone [MeSH concept]
- atovaquone [MeSH concept]
- mepron [MeSH concept]
Related MeSH Supplementary Concept(s)
- atovaquone, proguanil drug combination [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing atovaquone (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 1,4-naphthalenedione, 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-, trans- [Substance BNPC]
- Atovaquone [NCIt concept]
- Atovaquone [LOINC component]
- Atovaquone (substance) [SNOMED CT concept]
- Product containing atovaquone (medicinal product) [SNOMED CT concept]
- atovaquone [ATC Code]
Validated automatic mappings to BTNT
- atovaquone [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients